Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Testicular Neoplasms × Control Groups × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Urinary Incontinence 1 Testicular Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Castration-resistant Prostate Cancer 1

Interventions

Carboplatin 25 Etoposide 22 Ifosfamide 19 Filgrastim 18 Cisplatin 17 Peripheral Blood Stem Cell Transplantation 14 Paclitaxel 14 Cyclophosphamide 10 Radiotherapy 8 Bleomycin 8 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 Thiotepa 5 Therapeutics 5 Polymerase Chain Reaction 5 Granulocyte Colony-Stimulating Factor 5 Flow Cytometry 5 etoposide phosphate 4 Temozolomide 4 Melphalan 4 Busulfan 4 sargramostim 3 Vinblastine 3 Psychiatric Rehabilitation 3 Oxaliplatin 3 Methylprednisolone 3 Methods 3 Immunologic Techniques 3 Fluorodeoxyglucose F18 3 Epirubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577172 2017-01-26

TAST

Oslo University Hospital

Phase NA Terminated

Motor Activity, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡